Ticker	Volume	Price	Price Delta
DJIA	15,387.60	+52.30	0.34%
S&P 500	1,669.16	+2.87	0.17%
Nasdaq	3,502.12	+5.69	0.16%

Ticker

Volume

Price

Price Delta

DJIA

15,387.60

+52.30

0.34%

S&P 500

1,669.16

+2.87

0.17%

Nasdaq

3,502.12

+5.69

0.16%

Ticker	Volume	Price	Price Delta
STOXX 50	2,821.65	-2.85	-0.10%
FTSE 100	6,803.87	+48.24	0.71%
DAX	8,472.20	+16.37	0.19%

Ticker

Volume

Price

Price Delta

STOXX 50

2,821.65

-2.85

-0.10%

FTSE 100

6,803.87

+48.24

0.71%

DAX

8,472.20

+16.37

0.19%

Ticker	Volume	Price	Price Delta
Nikkei	15,664.80	+283.82	1.85%
Hang Seng	23,353.20	-13.16	-0.06%
S&P/ASX 200	5,162.90	-17.16	-0.33%

Ticker

Volume

Price

Price Delta

Nikkei

15,664.80

+283.82

1.85%

Hang Seng

23,353.20

-13.16

-0.06%

S&P/ASX 200

5,162.90

-17.16

-0.33%

Bio Light Climbs Most in 4 Months on Acquisition Talks

By Ronit Goodman - 2011-01-18T15:02:04Z

Bio Light Israeli Life Sciences Investments Ltd. rose the most in more than four months after the owner of companies that develop drugs and medical technology said an investor group is in talks to buy a controlling stake.

The shares surged 16 percent, the most since Sept. 6, to 0.428 shekel at the 4:30 p.m. close in Tel Aviv, giving the Ramat Gan-based company a market value of 40 million shekels ($11 million).

Investors led by Israel Makov are in discussions to purchase a 26.1 percent stake in Bio Light for about 10 million shekels, the company said in a statement to the Tel Aviv Stock Exchange today.

To contact the reporter on this story: Ronit Goodman in Tel Aviv at rgoodman9@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.